Cathelicidins Have Direct Antiviral Activity against Respiratory Syncytial Virus In Vitro and Protective Function In Vivo in Mice and Humans

Respiratory syncytial virus (RSV) is a leading cause of respiratory tract infection in infants, causing significant morbidity and mortality. No vaccine or specific, effective treatment is currently available. A more complete understanding of the key components of effective host response to RSV and n...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Immunol
Autori principali: Currie, Silke M., Gwyer Findlay, Emily, McFarlane, Amanda J., Fitch, Paul M., Böttcher, Bettina, Colegrave, Nick, Paras, Allan, Jozwik, Agnieszka, Chiu, Christopher, Schwarze, Jürgen, Davidson, Donald J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: AAI 2016
Soggetti:
Infectious Disease and Host Response
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4777919/
https://ncbi.nlm.nih.gov/pubmed/26873992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1502478
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi